Interim Analysis Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interim Analysis Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interim Analysis Plan Today - Breaking & Trending Today

FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial and Acurx Announces Presentations at ECCMID 2023 Scientific Conference

Published: April 11, 2023

FDA has accepted an Interim Analysis Plan for an IDMC to assess clinical outcome when 36 patients are enrolled in the Company's Ph2b clinical trial of...

Source: prnewswire.com

Related Topics:

United StatesKevin GareyUrsula TheuretzbacherRobertj DelucciaEuropean Society Of Clinical MicrobiologyExchange Commission On FormEuropean CongressPrnewswire Acurx Pharmaceuticals IncCompany PhInfectious Diseases Society Of AmericaDrug AdministrationExchange CommissionAcurx Pharmaceuticals IncTrial Oversight CommitteeUniversity Of Houston College PharmacyAcurx PharmaceuticalsInhibitor Program For Systemic BacterialData Monitoring CommitteeSociety Or Healthcare Epidemiology Of AmericaInterim Analysis PlanLead OptimizationIndependent Data Monitoring CommitteeInvestigational New Drug ApplicationAnnual European CongressClinical Microbiology